Free List Of Top 10 Bioinformatics Companies

Bioinformatics, an interdisciplinary field that combines biology, computer science, and statistics, has been rapidly advancing in the US. The convergence of these disciplines has led to groundbreaking discoveries, advancements in drug development, and personalized medicine. In this article, we’ll delve into the top 10 bioinformatics companies based in the US that are at the forefront of transforming healthcare through innovative technologies and data analysis.

Overview of the Top 10 Bioinformatics Companies in the US

1. Sector: Healthcare Technology

Year Founded: 1990

Annual Revenue: $2 billion (2019)

Description: Illumina is a global leader in D sequencing and array-based technologies, providing comprehensive solutions for genomics analysis. Their cutting-edge platforms serve a broad range of applications, from basic research to clinical and pharmaceutical analysis.

Link: [Illumina](https://www.illumina.com/)

2. Sector: Pharmaceutical Technology

Year Founded: 2005

Annual Revenue: $700 million (2019)

Description: Genuity Science, formerly known as WuXi NextCODE, is a contract organization that offers comprehensive genomics services, including sequencing, analysis, and insights for drug discovery and precision medicine.

Link: [Genuity Science](https://www.genuitysci.com/)

3. Sector: Precision Medicine

Year Founded: 2013

Annual Revenue: $200 million (2019)

Description: 23andMe is a personal genomics and biotechnology company that focuses on direct-to-consumer genetic testing. They provide insights into ancestry, traits, and health predispositions.

Link: [23andMe](https://www.23andme.com/)

4. Sector: Data Analytics

Year Founded: 2002

Annual Revenue: $500 million (2019)

Description: Dnexus is a cloud-based genome informatics and data management platform, offering scalable and secure solutions for genomic and biomedical data analysis.

Link: [Dnexus](https://www.dnanexus.com/)

5. Sector: Drug Development

Year Founded: 2014

Annual Revenue: $100 million (2019)

Description: Moderna is focused on pioneering messenger R (mR) technology to develop a new class of transformative medicines. Their platform is designed to propel drug discovery and development.

Link: [Moderna](https://www.modernatx.com/)

6. Sector: Genomics Research

Year Founded: 2009

Annual Revenue: $300 million (2019)

Description: Foundation Medicine is dedicated to transforming cancer care through comprehensive genomic profiling. Their products and services aim to provide actionable insights for patients and healthcare providers.

Link: [Foundation Medicine](https://www.foundationmedicine.com/)

7. Sector: Artificial Intelligence

Year Founded: 2015

Annual Revenue: $150 million (2019)

Description: Recursion Pharmaceuticals leverages AI and experimental biology to identify potential drug candidates for rare genetic diseases and other complex disorders.

Link: [Recursion Pharmaceuticals](https://www.recursionpharma.com/)

8. Sector: Clinical Diagnostics

Year Founded: 2008

Annual Revenue: $400 million (2019)

Description: Guardant Health specializes in non-invasive cancer diagnostics, utilizing advanced genomics to improve treatment decisions and patient outcomes.

Link: [Guardant Health](https://www.guardanthealth.com/)

9. Sector: Health Informatics

Year Founded: 2003

Annual Revenue: $600 million (2019)

Description: Dnexus provides an innovative cloud-based platform for analyzing and managing genomic and healthcare data, enabling collaborative research and precision medicine initiatives.

Link: [PerkinElmer](https://www.perkinelmer.com/)

10. Sector: Biopharmaceuticals

Year Founded: 2011

Annual Revenue: $250 million (2019)

Description: BlueBird Bio is dedicated to developing potentially transformative gene therapies for severe genetic diseases and cancer. Their innovative approach aims to redefine treatment options.

Link: [BlueBird Bio](https://www.bluebirdbio.com/)

End thoughts

The landscape of bioinformatics in the US is evolving rapidly, with these innovative companies leading the charge in driving advancements and breakthroughs in healthcare, pharmaceuticals, and genomics research. Their pioneering technologies and solutions are revolutionizing the way diseases are diagnosed, treated, and ultimately, cured. As bioinformatics continues to progress, these companies are at the helm of shaping the future of personalized medicine and precision healthcare in the United States.